How should we change in order to be successful in the future? - Strategy for Global Research

Situation
 

• Top ten pharma wishing to completely revise its Research strategy to address declining productivity
• New corporate strategy in place
• Globally dispersed and disconnected Research organization
• Limited ability to benefit from external innovation

Actions
 

• A 12 month, two phase program
• Phase I — Diagnostic — working with a team of senior clients to evaluate:
  • The likely evolution of the global healthcare and DA environment over the coming 20 years
  • The internal environment in terms of competencies and performance across all global Research sites
  • The competitive situation
• Phase II — Solution creation — a comprehensive new strategy for Research

Results
 

• Research strategy translated into:
  • New organizational structure enabling:
    • The creation of new decision-making bodies
    • New ways of creating strategies and managing the portfolio
  • Standardized terminology and methods across multiple sites
  • Optimization of the core discovery process including the identification of new KPIs
  • New competencies in accessing and managing external innovation